Report Detail

Request for Sample of this report

Other Global PEGylation Proteins Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4531071
    • |
  • 16 May, 2023
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global PEGylation Proteins Technology market size was valued at USD 1791.4 million in 2022 and is forecast to a readjusted size of USD 3598.8 million by 2029 with a CAGR of 10.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Poly(ethylene glycol) (PEG) is a widely used polymer in drug delivery systems and is often directly conjugated to a drug therapeutic. PEG is a water-soluble, biologically inert, non-immunogenic synthetic polymer consisted of ethylene glycol (-CH2-CH2-O-) in repeating units. PEG is produced by anionic polymerization of ethylene oxide initiated by a nucleophilic attack of a methoxide ion on the epoxide ring. PEGylation of a protein conjugate is the process by which PEG is either non-covalently or covalently attached to a potential protein, peptide or antibody of interest to produce alterations in the physiochemical properties of the macromolecule in areas like conformation, electrostatic binding and hydrophobicity. PEGylation is used as a strategy to overcome challenges such as instability, inadequate circulation half-life and immunogenicity of a drug candidate intended for a therapeutic use.
This report is a detailed and comprehensive analysis for global PEGylation Proteins Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PEGylation Proteins Technology market size and forecasts, in consumption value ($ Million), 2018-2029
Global PEGylation Proteins Technology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global PEGylation Proteins Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global PEGylation Proteins Technology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PEGylation Proteins Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PEGylation Proteins Technology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam Plc., Aurigene Pharmaceutical Services Ltd., BroadPharm, Creative PEGworks and Celares GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
PEGylation Proteins Technology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Colony-stimulating Factor
Interferons
Erythropoietin
Recombinant Factor VII
Others
Market segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Market segment by players, this report covers
Abcam Plc.
Aurigene Pharmaceutical Services Ltd.
BroadPharm
Creative PEGworks
Celares GmbH
Creative Diagnostics
Enzon Pharmaceuticals, Inc.
Laysan Bio, Inc.
Merck KGaA
NOF America Corp.
Pfizer
Profacgen
Thermo Fisher Scientific, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe PEGylation Proteins Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PEGylation Proteins Technology, with revenue, gross margin and global market share of PEGylation Proteins Technology from 2018 to 2023.
Chapter 3, the PEGylation Proteins Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and PEGylation Proteins Technology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of PEGylation Proteins Technology.
Chapter 13, to describe PEGylation Proteins Technology research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of PEGylation Proteins Technology
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of PEGylation Proteins Technology by Type
    • 1.3.1 Overview: Global PEGylation Proteins Technology Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global PEGylation Proteins Technology Consumption Value Market Share by Type in 2022
    • 1.3.3 Colony-stimulating Factor
    • 1.3.4 Interferons
    • 1.3.5 Erythropoietin
    • 1.3.6 Recombinant Factor VII
    • 1.3.7 Others
  • 1.4 Global PEGylation Proteins Technology Market by Application
    • 1.4.1 Overview: Global PEGylation Proteins Technology Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical & Biotechnology Companies
    • 1.4.3 Contract Research Organizations (CROs)
    • 1.4.4 Academic & Research Institutes
  • 1.5 Global PEGylation Proteins Technology Market Size & Forecast
  • 1.6 Global PEGylation Proteins Technology Market Size and Forecast by Region
    • 1.6.1 Global PEGylation Proteins Technology Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global PEGylation Proteins Technology Market Size by Region, (2018-2029)
    • 1.6.3 North America PEGylation Proteins Technology Market Size and Prospect (2018-2029)
    • 1.6.4 Europe PEGylation Proteins Technology Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific PEGylation Proteins Technology Market Size and Prospect (2018-2029)
    • 1.6.6 South America PEGylation Proteins Technology Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa PEGylation Proteins Technology Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Abcam Plc.
    • 2.1.1 Abcam Plc. Details
    • 2.1.2 Abcam Plc. Major Business
    • 2.1.3 Abcam Plc. PEGylation Proteins Technology Product and Solutions
    • 2.1.4 Abcam Plc. PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Abcam Plc. Recent Developments and Future Plans
  • 2.2 Aurigene Pharmaceutical Services Ltd.
    • 2.2.1 Aurigene Pharmaceutical Services Ltd. Details
    • 2.2.2 Aurigene Pharmaceutical Services Ltd. Major Business
    • 2.2.3 Aurigene Pharmaceutical Services Ltd. PEGylation Proteins Technology Product and Solutions
    • 2.2.4 Aurigene Pharmaceutical Services Ltd. PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Aurigene Pharmaceutical Services Ltd. Recent Developments and Future Plans
  • 2.3 BroadPharm
    • 2.3.1 BroadPharm Details
    • 2.3.2 BroadPharm Major Business
    • 2.3.3 BroadPharm PEGylation Proteins Technology Product and Solutions
    • 2.3.4 BroadPharm PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 BroadPharm Recent Developments and Future Plans
  • 2.4 Creative PEGworks
    • 2.4.1 Creative PEGworks Details
    • 2.4.2 Creative PEGworks Major Business
    • 2.4.3 Creative PEGworks PEGylation Proteins Technology Product and Solutions
    • 2.4.4 Creative PEGworks PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Creative PEGworks Recent Developments and Future Plans
  • 2.5 Celares GmbH
    • 2.5.1 Celares GmbH Details
    • 2.5.2 Celares GmbH Major Business
    • 2.5.3 Celares GmbH PEGylation Proteins Technology Product and Solutions
    • 2.5.4 Celares GmbH PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Celares GmbH Recent Developments and Future Plans
  • 2.6 Creative Diagnostics
    • 2.6.1 Creative Diagnostics Details
    • 2.6.2 Creative Diagnostics Major Business
    • 2.6.3 Creative Diagnostics PEGylation Proteins Technology Product and Solutions
    • 2.6.4 Creative Diagnostics PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Creative Diagnostics Recent Developments and Future Plans
  • 2.7 Enzon Pharmaceuticals, Inc.
    • 2.7.1 Enzon Pharmaceuticals, Inc. Details
    • 2.7.2 Enzon Pharmaceuticals, Inc. Major Business
    • 2.7.3 Enzon Pharmaceuticals, Inc. PEGylation Proteins Technology Product and Solutions
    • 2.7.4 Enzon Pharmaceuticals, Inc. PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Enzon Pharmaceuticals, Inc. Recent Developments and Future Plans
  • 2.8 Laysan Bio, Inc.
    • 2.8.1 Laysan Bio, Inc. Details
    • 2.8.2 Laysan Bio, Inc. Major Business
    • 2.8.3 Laysan Bio, Inc. PEGylation Proteins Technology Product and Solutions
    • 2.8.4 Laysan Bio, Inc. PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Laysan Bio, Inc. Recent Developments and Future Plans
  • 2.9 Merck KGaA
    • 2.9.1 Merck KGaA Details
    • 2.9.2 Merck KGaA Major Business
    • 2.9.3 Merck KGaA PEGylation Proteins Technology Product and Solutions
    • 2.9.4 Merck KGaA PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Merck KGaA Recent Developments and Future Plans
  • 2.10 NOF America Corp.
    • 2.10.1 NOF America Corp. Details
    • 2.10.2 NOF America Corp. Major Business
    • 2.10.3 NOF America Corp. PEGylation Proteins Technology Product and Solutions
    • 2.10.4 NOF America Corp. PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 NOF America Corp. Recent Developments and Future Plans
  • 2.11 Pfizer
    • 2.11.1 Pfizer Details
    • 2.11.2 Pfizer Major Business
    • 2.11.3 Pfizer PEGylation Proteins Technology Product and Solutions
    • 2.11.4 Pfizer PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Pfizer Recent Developments and Future Plans
  • 2.12 Profacgen
    • 2.12.1 Profacgen Details
    • 2.12.2 Profacgen Major Business
    • 2.12.3 Profacgen PEGylation Proteins Technology Product and Solutions
    • 2.12.4 Profacgen PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Profacgen Recent Developments and Future Plans
  • 2.13 Thermo Fisher Scientific, Inc.
    • 2.13.1 Thermo Fisher Scientific, Inc. Details
    • 2.13.2 Thermo Fisher Scientific, Inc. Major Business
    • 2.13.3 Thermo Fisher Scientific, Inc. PEGylation Proteins Technology Product and Solutions
    • 2.13.4 Thermo Fisher Scientific, Inc. PEGylation Proteins Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global PEGylation Proteins Technology Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of PEGylation Proteins Technology by Company Revenue
    • 3.2.2 Top 3 PEGylation Proteins Technology Players Market Share in 2022
    • 3.2.3 Top 6 PEGylation Proteins Technology Players Market Share in 2022
  • 3.3 PEGylation Proteins Technology Market: Overall Company Footprint Analysis
    • 3.3.1 PEGylation Proteins Technology Market: Region Footprint
    • 3.3.2 PEGylation Proteins Technology Market: Company Product Type Footprint
    • 3.3.3 PEGylation Proteins Technology Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global PEGylation Proteins Technology Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global PEGylation Proteins Technology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global PEGylation Proteins Technology Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global PEGylation Proteins Technology Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America PEGylation Proteins Technology Consumption Value by Type (2018-2029)
  • 6.2 North America PEGylation Proteins Technology Consumption Value by Application (2018-2029)
  • 6.3 North America PEGylation Proteins Technology Market Size by Country
    • 6.3.1 North America PEGylation Proteins Technology Consumption Value by Country (2018-2029)
    • 6.3.2 United States PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 6.3.3 Canada PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico PEGylation Proteins Technology Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe PEGylation Proteins Technology Consumption Value by Type (2018-2029)
  • 7.2 Europe PEGylation Proteins Technology Consumption Value by Application (2018-2029)
  • 7.3 Europe PEGylation Proteins Technology Market Size by Country
    • 7.3.1 Europe PEGylation Proteins Technology Consumption Value by Country (2018-2029)
    • 7.3.2 Germany PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 7.3.3 France PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 7.3.5 Russia PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 7.3.6 Italy PEGylation Proteins Technology Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific PEGylation Proteins Technology Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific PEGylation Proteins Technology Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific PEGylation Proteins Technology Market Size by Region
    • 8.3.1 Asia-Pacific PEGylation Proteins Technology Consumption Value by Region (2018-2029)
    • 8.3.2 China PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 8.3.3 Japan PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 8.3.5 India PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 8.3.7 Australia PEGylation Proteins Technology Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America PEGylation Proteins Technology Consumption Value by Type (2018-2029)
  • 9.2 South America PEGylation Proteins Technology Consumption Value by Application (2018-2029)
  • 9.3 South America PEGylation Proteins Technology Market Size by Country
    • 9.3.1 South America PEGylation Proteins Technology Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina PEGylation Proteins Technology Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa PEGylation Proteins Technology Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa PEGylation Proteins Technology Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa PEGylation Proteins Technology Market Size by Country
    • 10.3.1 Middle East & Africa PEGylation Proteins Technology Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia PEGylation Proteins Technology Market Size and Forecast (2018-2029)
    • 10.3.4 UAE PEGylation Proteins Technology Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 PEGylation Proteins Technology Market Drivers
  • 11.2 PEGylation Proteins Technology Market Restraints
  • 11.3 PEGylation Proteins Technology Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 PEGylation Proteins Technology Industry Chain
  • 12.2 PEGylation Proteins Technology Upstream Analysis
  • 12.3 PEGylation Proteins Technology Midstream Analysis
  • 12.4 PEGylation Proteins Technology Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on PEGylation Proteins Technology. Industry analysis & Market Report on PEGylation Proteins Technology is a syndicated market report, published as Global PEGylation Proteins Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of PEGylation Proteins Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,745.72
    		4,118.58
    		5,491.44
    		3,201.60
    		4,802.40
    		6,403.20
    		539,991.60
    		809,987.40
    		1,079,983.20
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo